**US3024913036 - Common Stock - After market: 120.97 0 (0%)**

Taking everything into account, **FMC** scores **4** out of 10 in our fundamental rating. **FMC** was compared to 121 industry peers in the **Chemicals** industry. **FMC** has a medium profitability rating, but doesn't score so well on its financial health evaluation. **FMC** is quite expensive at the moment. It does show a decent growth rate.

ROA (6.58%) VS Industry: 43% outperformed.

0.23

624.60

ROE (21.76%) VS Industry: 58% outperformed.

0.26

237.19

Profit Margin (12.67%) VS Industry: 64% outperformed.

0.51

45.08

With a **Price/Earnings Ratio** of **16.33**, **FMC** is valued correctly.

With a **Forward Price/Earnings Ratio** of **15.27**, **FMC** is valued correctly.

When comparing the current price to the book value of **FMC**, we can conclude it is valued correctly. It is trading at **4.48** times its book value.

Compared to an average industry **Price/Earning Ratio** of **12.03**, **FMC** is valued slightly more expensive.

The high **PEG Ratio**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

Compared to an average industry price book ratio of 1.90, **FMC** is valued more expensive than its industry peers. **85%** of the companies listed in the same industry are valued cheaper.

When comparing the **Enterprise Value to EBITDA** ratio of **FMC** to the average industry ratio of 9.27, **FMC** is valued more expensive than its industry peers.

Price/Earnings (16.33) VS Industry: 30% outperformed.

177.68

2.00

Price/Book (4.48) VS Industry: 15% outperformed.

764.36

0.02

Enterprise Value/ EBITDA (12.58) VS Industry: 30% outperformed.

13,692.96

0.15

The **Revenue** has grown by **15.01%** in the past year. This is quite good.

Measured over the past 5 years, **FMC** shows a quite strong growth in **Revenue**. The Revenue has been growing by **15.05%** on average per year.

The **Earnings Per Share** has been growing slightly by **6.93%** over the past year.

The **Revenue** is expected to grow by **2.90%** on average over the next 5 years.

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 22.28% | 6.82% | 6.93% | 6.93% | 10.13% | 10.74% | 8.48% |

Revenue | 15.05% | 7.97% | 15.01% | 7.81% | 6.32% | 5.37% | 2.9% |

A Current Ratio of **1.43** indicates that **FMC** should not have too much problems paying its short term obligations.

An Altman-Z score of **2.89** indicates that **FMC** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score is in line with the industry averages, which is at **2.52**.

Compared to an average industry Current Ratio of 2.02, **FMC** is worse placed to pay its short term obligations than its industry peers.

When comparing the Quick Ratio of **FMC** to the average industry Current Ratio of **1.32**, **FMC** is less able to pay its short term obligations than its industry peers.

Compared to an average industry Debt to Equity Ratio of **0.58**, **FMC** is more dependent on financing than its industry peers.

Debt/Equity (0.81) VS Industry: 35% outperformed.

53.61

0.00

Quick Ratio (1) VS Industry: 33% outperformed.

0.01

65.94

Current Ratio (1.43) VS Industry: 26% outperformed.

0.01

65.94

Altman-Z (2.89) VS Industry: 57% outperformed.

-529.46

142.65

The dividend of **FMC** is nicely growing with an annual growth rate of **9.83%**!

Compared to an average industry **Dividend Yield** of **2.26**, **FMC** is paying slightly less dividend.

Compared to the average S&P500 **Dividend Yield** of **2.60**, **FMC** is paying slightly less dividend.

Dividend Yield (2%) VS Industry: 40% outperformed.

0.30

22.94

NYSE:FMC (3/29/2023, 7:06:56 PM)**+1.72 (+1.44%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)02-07 2023-02-07/amc

Earnings (Next)05-01 2023-05-01/amc

Inst Owners90.69%

Inst Owner Change-0.3%

Ins Owners0.54%

Ins Owner Change7.53%

Market Cap15.13B

Analysts76.67

Price Target147.18 (21.67%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2% |

Dividend Growth(5Y)9.83%

DP36.4%

Div Incr Years5

Div Non Decr Years10

Ex-Date03-30 2023-03-30 (0.58)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)4.8%

Min EPS beat(2)0.81%

Max EPS beat(2)8.79%

EPS beat(4)4

Avg EPS beat(4)5.01%

Min EPS beat(4)0.81%

Max EPS beat(4)9.04%

Revenue beat(2)2

Avg Revenue beat(2)3.36%

Min Revenue beat(2)1.94%

Max Revenue beat(2)4.78%

Revenue beat(4)4

Avg Revenue beat(4)4.65%

Min Revenue beat(4)1.94%

Max Revenue beat(4)7.9%

PT rev (1m)1.11%

PT rev (3m)4.29%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-6.67%

EPS NY rev (1m)-5.91%

EPS NY rev (3m)-5.91%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)2.41%

Revenue NY rev (1m)2.24%

Revenue NY rev (3m)2.24%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.33 | ||

Fwd PE | 15.27 | ||

P/S | 2.61 | ||

P/FCF | 34.39 | ||

P/OCF | 25.99 | ||

P/B | 4.48 | ||

P/tB | N/A | ||

EV/EBITDA | 12.58 |

EPS(TTM)7.41

EY6.13%

EPS(NY)7.92

Fwd EY6.55%

FCF(TTM)3.52

FCFY2.91%

OCF(TTM)4.66

OCFY3.85%

SpS46.38

BVpS27

TBVpS-6.81

PEG (NY)2.36

PEG (5Y)0.73

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.58% | ||

ROE | 21.76% | ||

ROIC | 13.36% | ||

ROICexc | 14.42% | ||

ROICexgc | 34.6% | ||

OM | 20.6% | ||

PM | 12.67% | ||

GM | 40.1% |

ROICexgc(3y)32.63%

ROICexcg growth 3Y5.54%

ROICexcg growth 5Y20.31%

ROICexc(3y)13.75%

ROICexc growth 3Y6.02%

ROICexc growth 5Y19.17%

OM growth 3Y-0.42%

OM growth 5Y4.91%

PM growth 3Y7.05%

PM growth 5Y-7.41%

GM growth 3Y-3.91%

GM growth 5Y0.95%

F-Score5

Asset Turnover0.52

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.81 | ||

Debt/FCF | 7.44 | ||

Debt/EBITDA | 2.4 | ||

Cap/Depr | 84% | ||

Profit Quality | 59.89% | ||

Current Ratio | 1.43 | ||

Quick Ratio | 1 | ||

Altman-Z | 2.89 |

F-Score5

WACC9.06%

ROIC/WACC3.82

Cap/Depr(3y)86.88%

Cap/Depr(5y)95.42%

Profit Quality(3y)80.4%

Profit Quality(5y)69.34%

Growth

EPS 1Y6.93%

EPS 3Y6.82%

EPS 5Y22.28%

EPS growth Q2Q9.72%

EPS Next Y6.93%

EPS Next 2Y10.13%

EPS Next 3Y10.74%

EPS Next 5Y8.48%

Revenue growth 1Y15.01%

Revenue growth 3Y7.97%

Revenue growth 5Y15.05%

Revenue growth Q2Q14.74%

Revenue Next Year7.81%

Revenue Next 2Y6.32%

Revenue Next 3Y5.37%

Revenue Next 5Y2.9%

EBIT growth 1Y10%

EBIT growth 3Y7.51%

EBIT growth 5Y20.69%

EBIT Next Year24.08%

EBIT Next 3Y12.89%

EBIT Next 5Y9.3%

FCF growth 1Y-37.78%

FCF growth 3Y8.29%

FCF growth 5Y11.99%

OCF growth 1Y-28.98%

OCF growth 3Y6.04%

OCF growth 5Y11.66%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*